Odds ratio (OR) | 95 % CI | |
---|---|---|
Diagnosis | ||
PV | 1.2480 | 0.6123–2.5439 |
ET | 0.3440 | 0.1307–0.9053 |
PMF | 1.1892 | 0.5539–2.5531 |
Post-PV-MF | 2.8235 | 0.8964–8.8935 |
Post-ET-MF | 0.6079 | 0.0788–4.6904 |
MPN-U | 2.5130 | 0.6872–9.1897 |
Thrombotic/thromboembolic event in medical history | 2.7083 | 1.3578–5.4021 |
Splenomegaly (detected by palpation) | 2.2222 | 1.0095–4.8919 |
Low platelets (<100/nl) | 1.3120 | 0.5504–3.1275 |
High platelets (>1000/nl) | 1.1874 | 0.4401–3.2035 |
ASS | 1.1216 | 0.5539–2.2712 |
P2Y12 antagonist | 2.8292 | 0.9979–8.0213 |
Double platelet inhibition | 3.0500 | 0.9589–9.7016 |
Oral vitamin K antagonist | 1.9739 | 0.7695–5.0634 |
Rivaroxaban | 1.6092 | 0.1923–13.4665 |
Heparin | 5.6426 | 1.8360–17.3421 |